OS 211 Pill - pink round, 9mm
Pill with imprint OS 211 is Pink, Round and has been identified as Hydromorphone Hydrochloride Extended-Release 8 mg. It is supplied by Trigen Laboratories, LLC.
Hydromorphone is used in the treatment of Chronic Pain; Pain; Cough; Anesthetic Adjunct and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Hydromorphone 8 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for OS 211
Hydromorphone Hydrochloride Extended-Release
- Imprint
- OS 211
- Strength
- 8 mg
- Color
- Pink
- Size
- 9.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Trigen Laboratories, LLC
- National Drug Code (NDC)
- 13811-0701
- Inactive Ingredients
-
cellulose acetate,
ferrosoferric oxide,
hypromellose 2910 (5 mPa.s),
lactose monohydrate,
magnesium stearate,
polyethylene glycol,
sodium chloride,
titanium dioxide,
triacetin,
silicon dioxide,
FD&C Red No. 40,
hypromellose 2208 (100 mPa.s)
Note: Inactive ingredients may vary.
Related images for "OS 211"
More about hydromorphone
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (449)
- Drug images
- Latest FDA alerts (11)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Hydromorphone drug information
- Hydromorphone injection
- Hydromorphone rectal
- Hydromorphone (Injection) (Advanced Reading)
- Hydromorphone (Oral) (Advanced Reading)
Other brands
Dilaudid, Dilaudid-HP, Exalgo, Palladone
Professional resources
- HYDROmorphone monograph
- Hydromorphone (FDA)
- Hydromorphone Extended Release (FDA)
- Hydromorphone Injection (FDA)
- Hydromorphone Oral Solution (FDA)
Other brands
Dilaudid, Dilaudid-HP, Exalgo, Palladone
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
